ANDREW SCHIERMEIER Insider Trading $NTLA Intellia Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANDREW SCHIERMEIER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANDREW SCHIERMEIER. ANDREW SCHIERMEIER is EVP, Chief Operating Officer in Intellia Therapeutics, Inc. ($NTLA) and EVP, Dev and Corp Strategy in Intellia Therapeutics, Inc. ($NTLA).

ANDREW SCHIERMEIER in Intellia Therapeutics, Inc.

Trading Symbol: NTLA
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ANDREW SCHIERMEIER: EVP, Chief Operating Officer, EVP, Dev and Corp Strategy
Holdings: 18,033 shares
Current Value: $239,839
Latest Transaction: Mar 05 2021
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ANDREW SCHIERMEIER in Intellia Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA0.0013,125013,125
Mar 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA57.7178,7504,544,66378,750
Jan 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseM0.004,79200
Jan 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA0.004,79204,792
Jan 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA20.569,583197,0269,583
Jan 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...SellS55.861,37776,91916,65618 K to 16.7 K (-7.64 %)
Jan 05 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...BuyM0.004,792018,03313.2 K to 18 K (+36.19 %)
Jan 04 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseM13.481,50020,220148,500
Jan 04 2021NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...BuyM13.481,50020,22012,67311.2 K to 12.7 K (+13.43 %)
Mar 04 2020NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA13.40135,0001,809,000135,000
Mar 04 2020NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA13.4815,000202,20015,000
Aug 02 2019NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Chief Operatin ...Option ExerciseA18.0955,000994,95055,000
Mar 12 2019NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Dev and Corp S ...BuyP15.504,25065,8757,5003.3 K to 7.5 K (+130.77 %)
Mar 12 2019NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Dev and Corp S ...BuyP16.003,25052,0003,2500 to 3.3 K
Dec 20 2018NTLAIntellia Therapeut ...SCHIERMEIER ANDREWEVP, Dev and Corp S ...Option ExerciseA14.5881,0001,180,98081,000

Page:   1